Total submissions: 5
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Eurofins Ntd Llc |
RCV000360748 | SCV000340106 | uncertain significance | not provided | 2016-04-04 | criteria provided, single submitter | clinical testing | |
| Ce |
RCV000360748 | SCV000892072 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | ZIC2: BP3, BS1 |
| Invitae | RCV001855174 | SCV002185951 | uncertain significance | Holoprosencephaly 5 | 2023-12-23 | criteria provided, single submitter | clinical testing | This variant, c.1392_1406del, results in the deletion of 5 amino acid(s) of the ZIC2 protein (p.Ala466_Ala470del), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has been observed in individuals with holoprosencephaly (PMID: 19177455, 32022405). This variant is also known as c.1366_1380del. ClinVar contains an entry for this variant (Variation ID: 286609). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| Fulgent Genetics, |
RCV001855174 | SCV002788894 | uncertain significance | Holoprosencephaly 5 | 2022-03-08 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV002519243 | SCV003707876 | likely benign | Inborn genetic diseases | 2022-05-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |